RSV maternal vaccine cuts baby hospital admissions by up to 85%

Largest real-world study in England confirms premature infants protected by vaccination

A new UK Health Security Agency (UKHSA) study  Maternal RSV vaccination and reduced risk of hospitalisation for babies in England 2024/25, clearly shows the maternal respiratory syncytial virus (RSV) vaccination programme is providing over 80% protection for newborn infants, including those born prematurely.

The study found vaccination at least 2 weeks before the birth gave 81.3% protection. A narrow range of statistical uncertainty, 78.9% to 83.4%, means there is high confidence in the protective effect of the vaccine.  

The study, which analysed data from the first year of vaccine roll out (24/25), is believed to be the largest study in the world evaluating the effect of maternal RSV vaccination in preventing infants being hospitalised for RSV chest infection.  

RSV causes  bronchiolitis (infection and inflammation of the small airways of the lung) and is a major cause of hospital admission in infants.      

The maternal vaccination programme is offered to women from 28 weeks of pregnancy to protect newborns.  

The study followed nearly 300,000 babies born between September 2024 and March 2025, representing around 90% of all births in England during this period. Using routinely collected electronic health records, UKHSA researchers assessed the vaccine’s effectiveness in preventing hospital admissions. More than 4,500 hospitalisations occurred in this cohort, the vast majority in infants whose mothers had not been vaccinated.  

Getting the vaccine on time was best (in week 28 or soon after that), as babies born at least 4 weeks after their mother was vaccinated had nearly 85% protection. But importantly, even vaccination later in pregnancy still gives some protection, with vaccination as close as 10 to 13 days before birth reducing hospital admissions by 50%.  

The study, which will be presented today (18 Apri)l at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) global conference, also found that premature babies, who are particularly vulnerable to RSV, can be well protected, provided there is at least 2 weeks between vaccination and birth.  

Matt Wilson, Epidemiologist at UKHSA, presenter and lead author, said:  “Our evaluation of the first season of the programme in England gives important confirmation that maternal RSV vaccination is highly protective for newborn infants, over 80%, and that effectiveness reached nearly 85% when vaccination occurred at least 4 weeks before birth.  

“These findings are also particularly important for preterm infants, who are among the most vulnerable to severe RSV infection.  With sufficient time between vaccination and birth, we saw good levels of protection in these babies.

“Giving the vaccination early in the third trimester, as recommended by the World Health Organization, could protect most preterm infants, so it’s important that midwives and other healthcare workers offer vaccination on time with the schedule – and that pregnant women promptly take it up.”

Maternal RSV vaccine uptake in England continues to climb, reaching 55% during the study period and the latest data showing uptake rising to 64.1% for women who gave birth in November 2025.

Dr Conall Watson, Consultant Epidemiologist at UKHSA, one of the senior authors and national  programme lead for RSV, said:  “RSV can cause life-threatening chest infections for babies. Half of newborns will have caught RSV before they are a year old. As an expectant parent you have no idea if they are going to be severely ill or not.   

“Our analysis of the RSV vaccination programme in England is important confirmation of the results from the clinical trial, but this study is 40 times bigger and clearly shows the hugely beneficial effect on reducing hospital admission.

“Getting vaccinated in week 28 of pregnancy or soon after gives excellent protection to both term and preterm babies when they are tiny and most vulnerable to severe RSV. The RSV vaccine gives a brilliant boost to the pregnant woman’s immune system so it can pass antibodies through the placenta and protect the baby from the day they are born.”

Major new £1.5m Scottish project to focus on “sabotaging” cancer cells

SABOTAGING CANCER COULD OPEN DOOR TO NEW TREATMENTS

RESEARCHERS IN EDINBURGH AIM TO ‘TRICK’ BOWEL CANCER

SCIENTISTS in Edinburgh are launching a £1.5 million Cancer Research UK-funded study to find a way to ‘sabotage’ bowel cancer cells.

Cancer cells can often disguise themselves, preventing the immune system from recognising them as a threat and destroying them. The team, at the Institute of Genetics and Cancer (IGC) at the University of Edinburgh, aims to disrupt cancer’s DNA messaging system, causing errors that make the cells visible to immune defences.

Exploring how to trigger this vulnerability, the study’s long-term goal is to identify new treatments to tackle bowel cancer more effectively.

Project leader Dr Kevin Myant, of the Cancer Research UK Scotland Centre and IGC, said: “Around 85 per cent of patients with bowel cancer find immunotherapy isn’t effective for them. Our new project aims to explore why and find new ways to make bowel cancer more responsive to this type of treatment.

“Immunotherapy is exciting as it has the potential to be curative, not just manage the disease, and has the benefit of reducing side effects to patients.

“We hope this project will find a way to shine a light on bowel cancer cells so they are no longer invisible to our immune system, by disrupting the messages telling cancer cells to grow.”

Bowel cancer kills 16,800 people in the UK (1,700 in Scotland) every year and is increasingly being diagnosed in younger people.

A recent study by the American Cancer Society published in The Lancet Oncology showed early-onset bowel cancer rates in adults aged 25-49 are rising in 27 of 50 countries studied and at a faster rate in young women in Scotland and England than in young men.

Often, in cancer, the immune system doesn’t see cancer cells as a threat as they are generated from inside the body.

This research will focus on the body’s messaging system, RNA, which takes information from DNA and tells cells when to grow and where.

The team aims to sabotage this system, through a process called RNA splicing, to disrupt these messages and introduce errors which will effectively “light up” bowel cancer cells to the immune system so it can destroy them.

Cancer Research UK Director of Research, Dr Catherine Elliott, said: “Immunotherapies, where a patient’s own immune system is harnessed to tackle cancer, are a key area of cancer research and for some patients, they are providing transformational improvements but not all patients respond to them.

“Being able to use the power of our own immune system to tackle cancer could offer more effective treatments and lead to the kind of breakthroughs which can revolutionise cancer treatment and care.

“We need more research to understand the differences in patient responses to therapies and how to improve these, and Cancer Research UK is delighted to fund this innovative and potentially transformative research.”

Bowel cancer, also known as colorectal cancer, is the second most common cause of cancer deaths in the UK. Despite this, treatment options remain limited, particularly for patients who are diagnosed at later stages of the disease.

Scotland is disproportionately affected by the disease with around 4,000 people diagnosed each year.

Former Edinburgh College Photography Student wins prestigious National Prize

A former Edinburgh College photography student has been recognised for his outstanding work after winning the Gold Award at the prestigious Association of Photographers Emerging Talent Awards 2025 – with a little bit of help from his granny.

23-year-old Jack Currie graduated from the College in November 2024 after completing the BA (Hons) course in Professional Photography, before moving on to a career as a freelance advertising photographer.

Jack’s work is often inspired by quirky concepts, and it was his picture, “Gangster Granny”, featuring his late grandmother Margaret, that saw him scoop the top prize at the AOP’s annual awards.

Part of a series of digitally altered photographs showing his gran engaging in a range of “dangerous activities”, the striking image, which has already gained considerable attention and has been covered in the likes of The Guardian and Digital Camera World, sees Margaret on a skateboard grinding down a rail.

Jack, who used Photoshop and body doubles to bring the concept to life, says the reality of winning the award is still setting in: “Winning the AOP Emerging Talent Award was something I once only dreamed of. From applying, to being shortlisted, to becoming a finalist, all the way to the awards night itself, I genuinely didn’t think I was going to win.

“I used my own granny for the photo, and she sadly passed away only the week before we won the award. She was thrilled to hear I was a finalist and had every confidence we would win. I guess she was right.”

Jack’s career has followed an impressive trajectory since his graduation, working with companies including Nike, Lidl, Timberland and Birkenstock. He now splits his time working between London and Edinburgh and recently did a photo-shoot with Piers Morgan for a front-page splash on the Telegraph Magazine.

He’s encouraging other budding photographers to consider studying at Edinburgh College, saying it’s the perfect place to learn the craft: “My experience was genuinely amazing. I applied for three places when looking into photography courses, and Edinburgh College by far had the best facilities.

“For me, it didn’t feel like studying; it felt like perfecting my craft, practising, getting critiqued and building my portfolio. With all the lecturers being ex photographers, their insight into how the industry works was huge. Hearing how they did it and seeing what they achieved was a massive motivation boost.

“While still studying, I worked with clients like Schuh, Size?, and Graham’s Dairy. In my second year I flew to New York to collect awards for work I had shot for college briefs.

“And just before I graduated, I signed with a London based agent who still represents me today. There is no way I would have taken the steps I did without the guidance of the lecturers. Their support and their critique shaped me into the photographer I am today.”

Jon Lee, Jack’s former lecturer and course leader for photography at Edinburgh College, isn’t surprised to see his old student picking up the prize: “I’d like to congratulate Jack on his recent award, it’s well-deserved recognition for someone we always knew would go on to experience great success.

“We wish him all the best for his future career, and I’m sure everyone at the College will be keeping a close eye on his work”.

Despite winning such a notable award, Jack has no plans to slow down anytime soon, and has dreams of seeing his work featured in Times Square and Piccadilly Circus. You can keep up to date with Jack on his website.

Half of people with chest pain given all-clear for angina may be misdiagnosed using standard scan

A coronary angiogram does not detect microvascular angina, which is particularly common in women, so researchers say more tests are needed ~

 Half of people investigated for suspected angina and given the all-clear may be missing out on the correct diagnosis, based on a study funded by the British Heart Foundation, published in the journal Nature Medicine, and presented at the American Heart Association Scientific Sessions conference in New Orleans. 

The study involved 250 British people referred for a coronary angiogram after experiencing chest pain. Based on their scan results, these people did not have angina – the medical term for pain or tightness within the chest caused by reduced blood flow to the heart.  

However, when researchers gave these people an extra MRI scan, they found 51 per cent of people given the all-clear for angina actually had a form of it called microvascular angina. This is triggered by tiny blood vessels which can’t be seen using a standard coronary angiogram – where a thin tube is inserted into the wrist and up to the coronary arteries and an X-ray taken. The angiogram can only detect angina caused by blockages in the large coronary arteries. 

Researchers say blood flow scans should be used to follow up angiograms for every patient with unexplained chest pain, but that many regions of the UK do not currently offer this. 

Professor Colin Berry, senior author of the study from the University of Glasgow, said: “Further tests like the scan we used could help to reveal thousands more people with microvascular angina in the UK every year. Microvascular angina is currently particularly under-diagnosed in women. 

“We need these extra test results because people whose angiogram results suggest their chest pain is not heart-related can be sent home without medication, on the assumption that their symptoms are due to things like indigestion, anxiety or arthritis. 

“It is not uncommon for these people to then have to return to their GP multiple times, with continuing symptoms like chest pain and breathlessness.” 

Angina is a symptom of chest pain which can be caused by blockages or narrowing in the large coronary arteries which supply most blood to the heart. Microvascular angina used to be known as ‘cardiac syndrome X’ because it greatly confused doctors seeing patients with angina-like chest pains who didn’t have the expected narrowings or blockages in their coronary arteries.  

Now the name, coined in the 1970s, is no longer used because experts understand that the pain is caused by tiny arteries within the heart muscle – less than half a millimetre across – which play a crucial role in regulating blood supply to the heart. Women are more likely to have the condition than men, particularly around and after the time of menopause. 

Among the 250 people studied, all but six were judged to have chest pain that wasn’t heart-related based on their angiogram results. But the MRI scan found 123 of these people had microvascular angina – a diagnosis which is very clearly heart-related. 

The scan detects microvascular angina, which reduces blood flow to the heart, by showing inadequate blood supply after people are given a drug called adenosine, which mimics the demands of physical activity on the body. 

In the study, half of the 250 people were offered altered treatment based on their MRI scan result, if needed. Such treatment could include calcium channel blockers, which relieve angina and lower blood pressure, and aspirin and statins, which reduce their risk of heart attacks and strokes. 

This group were examined to see how receiving a new diagnosis, following further tests after a coronary angiogram, might change people’s lives. 

A better quality of life 

Researchers found quality of life was better for people whose treatment was changed based on their scan, compared to those whose treatment was not changed following their scan. This group also saw a bigger reduction in the frequency of their chest pain – from weekly to monthly on average. They had a larger reduction in their difficulty doing everyday activities, based on a questionnaire. 

A second questionnaire looked at people’s mobility, pain and discomfort, anxiety and depression and difficulties washing, dressing and performing normal daily activities. This also showed a greater improvement for people whose treatment changed based on their MRI scan. 

There is some evidence that having microvascular angina may increase the risk of having a heart attack or stroke, although this wasn’t seen in the 12-month period people were followed up in the study. 

People whose treatment was changed based on their MRI scan were found to have lower blood pressure, which may have been brought down by medications they were prescribed. They also had a lower weight, which researchers believe may have been a result of reduced chest pain making it easier to be active. 

Dr Sonya Babu-Narayan, clinical director at the British Heart Foundation and consultant cardiologist, said: “Coronary microvascular dysfunction, which is seen more commonly in women, is real. It can have a serious impact on people’s everyday lives, as they struggle with chest pain and breathlessness, and is often misunderstood.  

“Unfortunately, many people go undiagnosed, are misdiagnosed, or are only diagnosed after years of delay, because the diagnosis of inadequate blood supply in tiny coronary blood vessels slips through the net.  

“This important study shows that it doesn’t have to be this way – having heart MRI tests improved chest pain diagnosis, which in turn led to changes in treatment and better health.” 

There were 127 people diagnosed with microvascular angina, including 123 whose angiogram had wrongly suggested their pain was not heart-related. The angiogram diagnosis that their chest pain was not heart-related appeared correct for 155 people. 

The MRI scans used in the study revealed two people judged not to have heart-related chest pain by an angiogram, who in fact had hypertrophic cardiomyopathy – a genetic condition which can cause a life-threatening abnormal heart rhythm. Another two people had myocarditis – inflammation of the heart muscle which most people recover from following treatment. 

There are around 250,000 coronary angiograms performed across the UK every year. The MRI scans in this study were done at the Golden Jubilee University National Hospital in Clydebank, within the west of Scotland. 

These scans judged blood flow in the blood vessels of the heart, and included an algorithm assessing the difference in flow between the inner and outer area of the heart, which is not routinely available on the NHS. However researchers say conventional MRI scans would have a largely similar performance. 

On how the study results should change NHS practice, Professor Berry added: “An angiogram alone is not enough for most people with suspected angina, but in most regions of the UK this is all that is performed. 

“People should be offered an additional test to look at blood flow. That does not need to be an MRI scan like ours, as there are several alternative tests which might be helpful. These tests are needed because debilitating chest pain significantly reduces people’s physical and mental wellbeing, and their ability to go about their everyday lives.” 

The study was also supported by the Chief Scientist Office in Scotland. 

Wee Scientists Needed!

🔍Looking for wee scientists aged 17-19 months! 🔎

You and your child can help us understand how children learn new words by taking part in a 30-min study in our lab at the University of Edinburgh.

Please follow this link to register your interest:

https://forms.office.com/e/cgcGL0rkhz

or email us directly at ppls.phonotactics@ed.ac.uk

We look forward to welcoming you and your child to our lab!

Study shows hearing intervention may reduce risk of falls among older adults

New paper led by ENU’s Dr Adele Goman is the first randomised control trial of this kind

Hearing interventions such as hearing aids and regular audiology appointments have been linked to a reduction in the number of falls among older adults, according to a new paper led by Dr Adele Goman of Edinburgh Napier University’s School of Health & Social Care.

This research, published today in the Lancet Public Health journal, showed that participants with hearing loss who were randomly assigned best practice hearing care reported an average of 27% fewer falls over the course of three years compared to a control group.

Falls are a leading cause of injury for older people and have rising mortality rates, while hearing loss is highly prevalent among those aged 70 and above. However, existing evidence on the effect of hearing aids on falls is mixed, and limited by the methodology of previous studies.

Goman and her colleagues analysed data from the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) study, a three-year, unmasked, randomised controlled trial of adults aged 70–84 years in the USA designed to study the effect of intervention on cognitive abilities and other health outcomes, such as falls.

The ACHIEVE study was funded by the National Institute on Aging, part of the U.S. National Institutes of Health.  It was conducted by a consortium of eight universities in the United States and led by researchers at Johns Hopkins University, Baltimore, MD, USA.

The 977 ACHIEVE study participants, all of whom had hearing loss, were randomly assigned to either receive a hearing intervention or to a health education control intervention. Those randomly assigned to the hearing intervention were offered regular one-to-one audiologist appointments, bilateral hearing aids, the option of additional hearing assistive devices, device use support and educational materials. The health education control intervention group received the same number of appointments with a health educator and more broad educational content on healthy aging.

For this paper, participants were asked to report the number of falls they had experienced over a period of three years. Data indicate that participants who received the hearing intervention reported an average of 27% fewer falls over the course of three years compared to a control group.

Dr Goman’s is the first known large-scale randomised control trial that has examined the effect of hearing intervention on falls.

The researchers believe the reduced number of falls among the hearing intervention group could be down to improved auditory input enhancing spatial awareness, or from having to devote less attention to processing auditory input allowing for more attention to be placed on maintaining postural control.

They are now working on a follow-up study with participants to examine the longer-term effects of hearing intervention on brain health, falls, and other health outcomes.

Dr Adele Goman said: “Hearing loss has previously been associated with a greater risk of falling among older adults, but few studies have directly investigated the connection.

“It is possible that the benefit of improved hearing may have enhanced the spatial environmental awareness of these participants, or that the lower demand on cognitive resources for hearing allowed them to focus more on their movement.

“As this is the first study of its kind, more research is needed to establish our conclusion that hearing intervention may reduce the overall average rate of falls. Our ongoing follow-up will also aim to tell us more about the effect over a longer period of time.

“We hope that these findings have the potential to inform researchers and health professionals, and address a leading cause of injury among older people.”

Edinburgh College: Part-time courses starting in August

Apply for a part time course starting in August 2025!

If you are looking to advance your career, explore a passion, or take the next step after school, experience Edinburgh College.

Our part time courses starting in August 2025 are now open for application, giving you the flexibility to balance your studies with work and other commitments.

Edinburgh College’s state-of-the-art facilities, expert lecturers, and strong industry connections offer hands-on experience and skills for your future success.

Apply for a part time course starting in August 2025 on our website:

https://ow.ly/CUHU50Vak5b

#experienceedinburghcollege

#edinburghcollege

Animals in cities are adapting to climate change, research shows

A new study indicates animal populations living in urban areas show elevated resilience to stressful environmental conditions, with conservation implications.

Published last week in Ecology Letters, the study was conducted by Queen’s University Belfast in collaboration with the GEOMAR Helmholtz Centre for Ocean Research Kiel, Germany.

Researchers  tested the adaptability of aquatic species, such as blue mussel and amphipods, found in shorelines in urban environments exposed to high ship traffic, compared with those from a remote protected shore.

An urban area can be described as a human settlement with a high population density and an infrastructure of built environment.

The team exposed the animals from both habitat types to a range of environmental stressors under laboratory conditions.

The treatments, which were events or situations that cause stress, reflected current and predicted environmental conditions in the sea, such as rising temperatures, saltwater changes and increased carbon dioxide.

The research showed animal populations from urban areas, with higher temperatures and greater concentrations of pollutants, demonstrated significantly higher resilience to stressful environmental conditions when compared to their counterparts from protected habitats.

Dr Ross Cuthbert from the School of Biological Sciences at Queen’s, was part of the international team of researchers, he said: “Our findings indicate that the populations of species differ substantially in their susceptibility to stressors associated with urbanisation.

“These results have important conservation implications, however, it remains to be seen whether these adaptations can keep pace with the rate of human-induced environmental changes relating to climate change such as pollution, burning fossil fuels, deforestation, and more.”

Urban habitats are very different from natural habitats and pose new challenges for animals and plants.

The research was led by Dr Elizabeta Briski, a marine biologist at the GEOMAR Helmholtz Centre for Ocean Research, she said: “The results show that populations from urbanised habitats tend to be more robust to these environmental stressors and, are already adapting to changing conditions.

“These populations could serve as potential ‘rescue populations’ for endangered populations. At the same time, their greater tolerance to future environmental changes could make it easier for them to conquer new habitats. This makes them potential invasive species that can be spread by human trade and transport between urban centres.”

Dr Cuthbert adds: “Until now, little was known about how populations of the same species evolve in habitats with and without human influence.

“While the tested species do not directly affect human health, if the processes found indeed worsen invasion risks in general, they could exacerbate known health risks from biological invasions, such as through spread of disease.”

The results of the study support the hypothesis that urban habitats can provide important clues about how animals will adapt to future environmental changes.

Edinburgh part of major cancer study

PROJECT TO INVESTIGATE LONG-STANDING CANCER MYSTERY

Scientists are seeking participants in Edinburgh and the Lothians to help solve one of the longest standing mysteries in cancer – how and why it can take decades for mesothelioma to develop after exposure to asbestos. 

The Cancer Research UK-funded project, Meso-ORIGINS led by Professor Kevin Blyth at the University of Glasgow, aims to find a way to detect and treat mesothelioma earlier and investigate if the disease can be prevented in the first place.

Mesothelioma is a cancer which develops in the pleural space, the lining of the lung, and is caused by exposure to asbestos. Only a small proportion of patients with inflammation of the pleural space go on to develop mesothelioma. Asbestos fibres can embed themselves in different parts of the lungs so the disease can develop at different rates in different parts of the pleural space.

Only around 4 in 10 (44.3%) people diagnosed with mesothelioma in Scotland survive their disease for one year or more making new ways to detect it and treat it earlier vital.*

The research team are keen to recruit people in Edinburgh and the Lothians already diagnosed with benign (non-cancerous) inflammation in the lungs, who may have been exposed to asbestos.

The Western General in Edinburgh is among 28 hospitals across the UK currently recruiting patients, with the project extending over the next two years. Eligible patients who attend these hospitals will be offered the chance to take part in the study and contribute to mesothelioma research.

Vital data and tissue samples from participants will help build a picture of who is at most risk of developing mesothelioma and identify any genetic differences or biological markers which indicate a predisposition to the disease.

Dr Alexandrea MacPherson, Meso-ORIGINS Project Manager at the University of Glasgow, said: “Mesothelioma is a disease of time and space – after initial exposure to asbestos it can evolve over decades at different times and different places within the pleural space.

“We want to understand why mesothelioma takes so long to develop and to discover new ways of predicting the disease so it can be caught early.

“Once diagnosed there are very few effective treatments so discovering the signs before it begins, and finding a way to prevent it developing, is key.”

Mesothelioma currently has a very poor survival rate and can take more than 40 years to develop. Early symptoms such as chest pain, fatigue and constant coughing can be overlooked because they resemble other illnesses.

According to Cancer Research UK, the UK currently endures the highest incidence of mesothelioma worldwide, with the disease more prevalent in men due to occupation-related exposure, and around 200 new cases in Scotland each year.**

There was widespread industrial use of asbestos between 1950 and 1980, particularly in Glasgow and surrounding areas as the material was manufactured in nearby towns such as Clydebank and used in heavy industry like ship building, which the River Clyde was famed for.

Research funded by Cancer Research UK revealed there are no safe levels of working with asbestos. This led to health and safety policies to protect future generations from mesothelioma and the charity continues to invest in finding new ways to beat the devastating disease. 

While asbestos has been illegal to use in the UK since the early 1990s, mesothelioma cases have increased in recent years due to the long period of time it can take to develop, and asbestos remains legal in other countries.

Dr Catherine Elliott, Cancer Research UK Director of Research, said: “Mesothelioma, despite asbestos being outlawed decades ago, is increasingly being diagnosed and is in desperate need of more effective treatments.

“Cancer Research UK is delighted to support this research project which aims to shed a light on why it can take years to develop after someone is exposed to asbestos.

“Long-term in-depth research projects like this are essential to developing our understanding of cancer and helping us find ways to stop it in its tracks.”

For information on how to join the project please speak to your clinician. To find out more go to: https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-to-find-out-more-about-mesothelioma-meso-origins.

Napier nursing researcher to lead study aiming to improve HIV/AIDS care in Ghana

Dr Mary Abboah-Offei’s trial has been backed by a £1.5m grant

A study led by Edinburgh Napier University (ENU) will look at how health care for people living with HIV/AIDS in Ghana can be improved – after securing a major grant of around £1.5m.

The trial of community-based, person-centred care will see healthcare professionals trained to offer a more holistic way of managing the condition.

The study, titled ExtraCECI (Extra community-based enhanced care intervention) aims to recruit around 650 patients. A smaller feasibility study of CECI suggested that participants felt the approach had the potential to improve their quality of life.

ExtraCECI is now set to get underway in May, after being backed by £1,468,810 in funding from the Medical Research Council.

Led by Dr Mary Abboah-Offei from ENU’s School of Health and Social Care, it will also involve academics and researchers from Kings College London, the University of York, and the University of Ghana.

If successful, the research could provide evidence to help make ExtraCECI a part of routine HIV/AIDS care in Ghana.

Dr Abboah-Offei, who is from Ghana, began her journey in healthcare research by working as a nurse in emergency care there.

This grant – one of the largest of its kind for an ENU researcher – represents a significant achievement for an early career academic with a background in nursing.

ExtraCECI will see medics from randomly selected HIV clinics trained to give a holistic assessment of the physical, psychological, social, and spiritual wellbeing, of their patients. This will then allow them to work together to plan and deliver their care.

Information will then be collected at regular intervals to see if the person-centred approach to care brings about any improvement in health outcomes.

Dr Mary Abboah-Offei said: “I am delighted to have the opportunity to begin this study. Having previously worked in healthcare in my home country, this feels like a way of giving back.

“Our previous research found that people living with HIV/AIDS there were experiencing distressing symptoms and concerns, even while taking their medication. This person-centred intervention approach aims to improve that.

“We found that patients were thrilled to have the opportunity to have a say in their treatment – while healthcare professionals found it eye-opening.

“I hope this wider trial can lead to a better quality of life for people living with these conditions.”

Professor Andrea Nolan, Principal and Vice Chancellor of Edinburgh Napier University, said: “Securing such a significant level of backing for this programme of work is a major achievement for Mary.

“Given her background in nursing, she will be well aware how ExtraCECI has the potential to make a positive difference to people’s lives in Ghana.

“Mary’s colleagues at Edinburgh Napier University will support her and the multidisciplinary team to deliver successful outcomes.”